"Corroding bacilli," so called because of their ability to form pits in the surface of blood agar medium, have been described by Henriksen (2, 3) , Eiken (1), and Hill et al. (4) . Initially classified as Bacteroides corrodens by Eiken (1) because of their failure to grow in the presence of oxygen, other strains of identical morphology and colonial appearance were later shown to be facultatively anaerobic (3) . Since Bacteroides is restricted to anaerobic organisms, it was suggested by Jackson and Goodman (6) that the facultatively anaerobic strains be transferred to a new genus, Eikenella. Gas-phase differences were further supported by those in deoxyribonucleic acid-base compositions. Robinson and James (7) , investigating the serology of corroding bacilli, showed that there were at least two antigenically distinct groups of B. corrodens, NC-1 and NCL-20. NCL-20 reacted with NC-1 and with Eikenella corrodens, but no reaction was given between NC-1 and E. corrodens.
In this study, 40 strains of corroding bacilli, comprising 16 belonging to B. corrodens serogroup NC-I, 4 from B. corrodens serogroup NCL-20, and 20 from E. corrodens serogroup AC-5, were tested against 10 chemotherapeutic agents to determine in vitro susceptibility.
All cultures were incubated in both the presence and absence of carbon dioxide to determine its effect on their susceptibility to the various chemotherapeutic agents.
MATERIALS AND METHODS Chemotherapeutic agents. The following were selected because of their routine use in clinical practice: ampicillin, clindamicin, chloramphenicol, demethylchlortetracycline, erythromycin, gentamicin, lincomycin, metronidazole, nalidixic acid, and penicillin G.
Organisms. All strains tested had been isolated from clinical material submitted to a hospital laboratory for routine bacteriological examination. Strictly anaerobic strains were isolated mainly from the genitourinary tract, and facultatively anaerobic strains were isolated from the upper respiratory tract. The following strains were used: B. corrodens NC-I group (NC-I, NC-2, and NC-1O1 to 114); B. corrodens NCL-20 group (NCL-20 and NCL-141 to 143); and E. corrodensAC-5 group (AC-4 to 10 and AC-202 to 214).
Estimation of MIC and MBC. To determine the minimal inhibitory concentration (MIC), the chemotherapeutic agent under test was prepared in sterile distilled water immediately before use and was added to brain heart infusion agar (pH 7.2) (Oxoid) at 44 C to give the required concentration. Defibrinated horse blood (10% vol/vol) (Oxoid) was then added, and 22 ml of this mixture was poured into sterile plastic petri dishes (90 mm in diameter). The plates were then dried to remove condensation. Brain heart infusion broth (Oxoid) containing 109 organisms per ml was prepared by using Brown's standard opacity tubes, and 0.05 ml of this suspension was added to the medium in the plate and spread over the surface. Two plates were similarly prepared for each strain: B. corrodens were incubated in a combined 90% hydrogen and 10% carbon dioxide atmosphere and also in hydrogen only; E. corrodens were incubated in carbon dioxide (candle jar) and also under normal aerobic conditions. All cultures were incubated for 3 days at 37 C, after which they were examined and the MIC was expressed in terms of the lowest concentration of chemotherapeutic agent that totally inhibited visible growth.
To determine the minimal bactericidal concentration (MBC), the chemotherapeutic agent was added to brain heart infusion broth (Oxoid) to give the required concentration. This preparation was distributed in 10-ml amounts into universal bottles each containing 1.0 g of meat granules (prepared as for Robertson's cooked meat medium). To each bottle was added 0.075 ml of the brain heart infusion containing 109 organisms per ml. The bottles were placed in a roller apparatus set at 2 rpm, and the whole was incubated at 37 C for 3 days. On the 4th day, 0.05 ml was removed from each broth culture and inoculated on to a separate blood agar plate. Subcul-tures were incubated for 3 days at 37 C, and the MBC was expressed in terms of the lowest concentration of chemotherapeutic agent in broth to yield no growth on subculture.
RESULTS
After the estimation of MIC and MBC of each chemotherapeutic agent for all strains, the organisms were grouped serologically; the range and mean for each group are reported in Tables 1  and 2 .
The main differences between mean readings of serogroup NC-I, NCL-20, and AC-5 are given below.
Ampicillin. Organisms in all three groups were inhibited by 0.5 ug/ml and killed by 1.0 Jg/ml.
Clindamicin. Groups NC-I and NCL-20 were inhibited by 0.8 jg/ml and killed by 8.3 jig/ml.
Group A C-5 was inhibited only by a concentration of 55.0 gg/ml and killed by 56.0 ,g/ml.
Chloramphemicol. Although both AC-5 and NC-I groups were inhibited by 2.0 gg/ml, whereas AC-5 was killed by 5.1 ug/ml, NC-I required a concentration in excess of 100 ,ug/ml.
Group NCL-20 was inhibited by 6.9 gg/ml and killed by 15.4 ,g/ml.
Demethylchlortetracycline. Again both AC-5 and NC-I groups were inhibited by a low concentration (2.1 ,ug/ml), but whereas AC-5 was killed by 5.6 ,ug/ml, NC-I required a concentration of 25.5 ug/ml. Group NCL-20 was inhibited by 7.7 ,g/ml and killed by 34.0 ,sg/ml.
Erythromycin. The differences between test cultures incubated in the presence and absence of carbon dioxide were marked. Inhibitory concentrations in the absence of carbon dioxide were similar (NC-I, 4.0 ,ug/ml; NCL-20, 4 .0 jug/ml; and AC-5, 2.4 gg/ml) and were also similar in the presence of carbon dioxide (NC-I, (>100) (>100) NC-I, 22.5 Ag/ml; NCL-20, 9.7 Agg/ml; and AC-5, 11.2 gg/ml.
Gentamicin. Groups NC-I and NCL-20 were inhibited by 0.4 gg/ml; NC-I was killed by 1.4 ug/ml and NCL-20 was killed by 0.2 gg/ml. Group AC-5 was inhibited by 1.7 ,g/ml and killed by 2.5 ug/ml.
Lincomycin. In the presence of carbon dioxide, NC-I was inhibited only by a concentration of 7.6 ,g/ml, whereas in the absence of carbon dioxide, it was inhibited by 3.5 gg/ml and killed by 15.4 ,g/ml. In the presence of carbon dioxide, NCL-20 was inhibited only by 11.8,ug/ml, whereas in the absence of carbon dioxide, it was inhibited by 2.5 gg/ml and killed by 3.2 tg/ml.
A concentration of 100 ug/ml failed to inhibit A C-5 in the presence or absence of carbon dioxide.
Metronidazole. Group NC-I was inhibited by 3.2 gg/ml and killed by 6.8 jg/ml; was inhibited by 1.2 MWml and killed by 1.4 jig/ml; AC-5 was not inhibited even by 100 sg/ml. Nalidixic acid. A contrary effect was encountered when cultures were incubated in the presence of carbon dioxide; group NCL-20 was inhibited by 26.0 j,g/ml with carbon dioxide but only by 62.0 jig/ml without. Group AC-5 was inhibited by 7.2jig/ml with carbon dioxide and by 8.4 jg/ml without. Group NC-I was not inhibited by 100 ug/ml with or without carbon dioxide.
Penicillin G. Groups NC-I and NCL-20 were inhibited by 0.5 ,ug/ml; NC-I was killed by 4.2 jig/ml and NCL-20 was killed by 0.2 ;g/ml.
Group AC-5 was inhibited by 1.5 ug/ml in the presence of carbon dioxide and by 0.8 jig/ml in its absence: AC-5 was killed by 0.9 Ag/ml.
We wish to emphasize that the foregoing constitutes comparisons of mean concentrations only and that the MIC and MBC of certain strains were substantially higher or lower than the values considered here.
DISCUSSION
Although differentiation based on chemotherapeutic susceptibility patterns has its limitations, the notable differences between the susceptibility of B. corrodens (NC-I and NCL-20 groups) to clindamicin, lincomycin, and metronidazole, and the relative susceptibility of E. corrodens (AC-5) to nalidixic acid, are too great to be discounted. Similarly, the high MBC of chloramphenicol (> 100 ,g/ml) in relation to MIC (2.0 ig/ml) for group NC-I compared with that of NCL-20 (MIC, 6 .9 jig/ml; MBC, 15.4 jig/ml) and the relative resistance of group NCL-20 to demethylchlortetracycline compared with NC-I could indicate essential differences between these groups.
We do not believe that the effect of carbon dioxide on in vitro susceptibility tests (5) in the case of certain chemotherapeutic agents is sufficient to warrant the provision of at least four alternative gas-phase conditions in routine bacteriological procedure. Since most anaerobic bacteria grow better in a carbon dioxideenriched atmosphere (8) , we believe that susceptibility tests incubated in the presence of carbon dioxide are justifiable on these grounds. 
